By Mattie Toma, Warwick Business School, University of Warwick Wellbeing at work is being taken more seriously by many businesses these days. After all, recent research has shown that more than a quarter of Generation Z workers – those born between 1997 and 2012 – seek out workplace benefits that help them cope with stress.…
Environmental factors in the bedroom like air pollution, warmth, high levels of carbon dioxide, and ambient noise have been linked to a drop in sleep efficiency, according to a study published in Sleep Health. Researchers with the Perelman School of Medicine at the University of Pennsylvania and the University of Louisville measured multiple environmental variables…
The US Food and Drug Administration (FDA) has granted Noctrix Health its De Novo request for the NTX100 Tonic Motor Activation System to treat symptoms of moderate to severe restless legs syndrome (RLS) and improve sleep quality in patients refractory to medications. The FDA previously granted a Breakthrough Device Designation for the therapy in May…
A drug approved by the US Food and Drug Administration to treat insomnia may have potential as a repurposed drug for the prevention of Alzheimer’s disease, according to a new study published in the Annals of Neurology. Sleep disturbances can be an early sign of Alzheimer’s disease. Many people eventually diagnosed with Alzheimer’s start experiencing…
By Pedram Navab, DO, FAASM, Esq As sleep specialists know, cognitive behavioral therapy is the gold standard and most effective manner to treat insomnia in the long run. Within this insomnia therapy rubric are muscle relaxation, breathing exercises, guided imagery, and stories that can facilitate sleep. 1. Muscle Relaxation Muscle relaxation involves focusing attention on…
Why haven’t you joined that church you love? Maybe that question applies to you right now. It certainly applied to me at a particular season in my life. I had been going to the same church for more than a year. The preaching was faithful, and the people were warm and sincere. I had come…